viemed is a respiratory disease management company. our mission is to educate, nurture, and inspire our patients to lead better lives. we accomplish this through a highly effective home treatment model that integrates easily into the processes of our referral partners to effectively transition patients from the hospital to their home or other long-term care setting. while our respiratory care practitioners, trained as copd educators, deliver therapy and counseling to patients in their home utilizing the most effective technology available, our care consultants work with hospitals, aco’s, snf’s and other referral sources to simplify the administrative process of transitioning patients from hospital to home care. we achieve industry leading outcomes in hospital readmissions and patient satisfaction which has resulted in us becoming one of the largest home non-invasive ventilation providers in the usa.
Company profile
Ticker
VMD
Exchange
Website
CEO
Casey Hoyt
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
Viemed, Inc. • Home Sleep Delivered, L.L.C. • Sleep Management, L.L.C. • Viemed Clinical Services, LLC • Viemed Healthcare Staffing, LLC • Viemed Real Estate Holdings, LLC • Home Medical Products, Inc. • Schofield Homecare Services, Inc. • Spirocare DME, LLC ...
VMD stock data
Latest filings (excl ownership)
ARS
2023 FY
Annual report to shareholders
26 Apr 24
DEF 14A
Definitive proxy
26 Apr 24
DEFA14A
Additional proxy soliciting materials
26 Apr 24
8-K
Forging Partnership with East Alabama Health
2 Apr 24
8-K
Regulation FD Disclosure
11 Mar 24
10-K
2023 FY
Annual report
6 Mar 24
8-K
Viemed Healthcare Announces Record 2023 Financial Results
6 Mar 24
8-K
Regulation FD Disclosure
7 Dec 23
8-K
Regulation FD Disclosure
7 Nov 23
10-Q
2023 Q3
Quarterly report
1 Nov 23
Transcripts
VMD
Earnings call transcript
2023 Q3
2 Nov 23
VMD
Earnings call transcript
2023 Q2
10 Aug 23
VMD
Earnings call transcript
2023 Q2
10 Aug 23
VMD
Earnings call transcript
2023 Q1
9 May 23
VMD
Earnings call transcript
2023 Q1
9 May 23
VMD
Earnings call transcript
2022 Q4
3 Mar 23
VMD
Earnings call transcript
2022 Q3
2 Nov 22
VMD
Earnings call transcript
2022 Q2
4 Aug 22
VMD
Earnings call transcript
2022 Q2
3 Aug 22
VMD
Earnings call transcript
2022 Q2
3 Aug 22
Latest ownership filings
4
Casey Hoyt
25 Mar 24
SC 13D/A
Moore Michael
15 Feb 24
SC 13G/A
Hoyt Casey
15 Feb 24
SC 13G
Nantahala Capital Management, LLC
14 Feb 24
SC 13G/A
THRIVENT FINANCIAL FOR LUTHERANS
13 Feb 24
SC 13G
BlackRock Inc.
2 Feb 24
4
Jeremy Trahan
30 Jan 24
4
Michael Moore
30 Jan 24
4
Casey Hoyt
30 Jan 24
4
Trae Fitzgerald
30 Jan 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 10.08 mm | 10.08 mm | 10.08 mm | 10.08 mm | 10.08 mm | 10.08 mm |
Cash burn (monthly) | 48.67 k | 950.00 k | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 336.23 k | 6.56 mm | n/a | n/a | n/a | n/a |
Cash remaining | 9.74 mm | 3.51 mm | n/a | n/a | n/a | n/a |
Runway (months of cash) | 200.2 | 3.7 | n/a | n/a | n/a | n/a |
Institutional ownership, Q2 2023
62.6% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 101 |
Opened positions | 34 |
Closed positions | 16 |
Increased positions | 26 |
Reduced positions | 28 |
13F shares | Current |
---|---|
Total value | 230.61 bn |
Total shares | 24.28 mm |
Total puts | 1.70 k |
Total calls | 9.00 k |
Total put/call ratio | 0.2 |
Largest owners | Shares | Value |
---|---|---|
Thrivent Financial For Lutherans | 3.51 mm | $34.51 bn |
Forager Capital Management | 1.94 mm | $19.02 bn |
BLK Blackrock | 1.91 mm | $18.72 bn |
Nantahala Capital Management | 1.73 mm | $16.90 bn |
Hillsdale Investment Management | 1.65 mm | $16.13 bn |
Vanguard | 1.14 mm | $11.20 bn |
AWM Investment | 1.10 mm | $10.73 bn |
Wasatch Advisors | 1.09 mm | $10.64 bn |
Acadian Asset Management | 847.70 k | $8.28 mm |
Cove Street Capital | 743.73 k | $7.27 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
22 Mar 24 | Hoyt Casey | Common Shares | Gift | Dispose G | Yes | No | 0 | 26,000 | 0.00 | 1,984,943 |
29 Jan 24 | Hoyt Casey | RSU Common Shares | Grant | Acquire A | No | No | 0 | 119,386 | 0.00 | 119,386 |
29 Jan 24 | Hoyt Casey | Phantom Share Units Common Shares | Grant | Acquire A | No | No | 0 | 39,796 | 0.00 | 39,796 |
29 Jan 24 | Trae Fitzgerald | RSU Common Shares | Grant | Acquire A | No | No | 0 | 29,383 | 0.00 | 29,383 |
29 Jan 24 | Trae Fitzgerald | Phantom Share Units Common Shares | Grant | Acquire A | No | No | 0 | 9,794 | 0.00 | 9,794 |
29 Jan 24 | William Todd Zehnder | RSU Common Shares | Grant | Acquire A | No | No | 0 | 80,527 | 0.00 | 80,527 |
29 Jan 24 | William Todd Zehnder | Phantom Share Units Common Shares | Grant | Acquire A | No | No | 0 | 26,842 | 0.00 | 26,842 |
29 Jan 24 | Jerome Cambre | RSU Common Shares | Grant | Acquire A | No | No | 0 | 25,857 | 0.00 | 25,857 |
29 Jan 24 | Jerome Cambre | Phantom Share Units Common Shares | Grant | Acquire A | No | No | 0 | 8,619 | 0.00 | 8,619 |
News
Viemed Announces Acquisition Of Majority Interest In HomeMed, Forging Partnership With East Alabama Health; Viemed Expects Incremental Annualized Revenue From The Acquired Operations Of ~$4M
2 Apr 24
Viemed Healthcare Q4 EPS $0.09 Misses $0.10 Estimate, Sales $50.74M Beat $50.00M Estimate
6 Mar 24
Earnings Scheduled For March 6, 2024
6 Mar 24
Viemed Healthcare's Earnings Outlook
5 Mar 24